New form of insulin can be inhaled rather than injected

Scientists today described a new ultra-rapid acting mealtime insulin (AFREZZA(TM)) that is orally inhaled for absorption via the lung. Because the insulin is absorbed so rapidly, AFREZZA's profile closely mimics the normal early insulin response seen in healthy individuals. AFREZZA is awaiting approval by the U. S. Food and Drug Administration (FDA). This presentation took place at the 239th American Chemical Society National Meeting, being held here this week.

Read the whole article on Physorg

More from Physorg